On December 15, 2022 TRANSGENE (Paris:TNG) reported that Management will participate in several investor events in January and February 2023, as set out below (Press release, Transgene, DEC 15, 2022, View Source [SID1234625337]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Transgene will meet institutional investors at the 12th Annual LifeSci Advisors Corporate Access Event and at BIO Partnering at JPM in San Francisco from January 9 to 12, 2023, in conjunction with the J.P. Morgan Healthcare conference.

The Company will also attend:

26th ODDO BHF Forum (virtual): January 9-10, 2023;
Invest Securities Biomed Forum: January 24, 2023;
Degroof Petercam’s Virtual Healthcare Conference: January 27, 2023;
BIO CEO & Investor Forum (New York): February 6-9, 2023.